Researchers Initiated Antibacterial Wound Dressing Project
The international AntiMicroMXen project aims to combine bacteriophages and nanomaterials to accelerate chronic wound healing.
Updated on Oct. 1, 2026 in Materials Science
Live Poll
Should medical researchers prioritize developing natural alternatives to treat infections over traditional antibiotic treatments?
Beginning in June 2024, the AntiMicroMXen project launched a multi-institutional research effort to develop electrospun wound dressings. The research, which remains in the development stage, integrates active ingredients into membranes to address chronic wounds.
Why it matters
The project targets antibiotic resistance and wound closure for patients with conditions such as diabetes. It seeks to reduce the high economic burden of chronic wound management, which currently totals 7.5 billion euros annually in Germany alone.
The researchers utilize electrospinning to deposit fibers from a polymer solution within an electric field. This process embeds bacteriophages—viruses that infect bacteria—alongside proteins and MXenes into the membrane structure.
The players
Fraunhofer Institute for Ceramic Technologies and Systems IKTS
A German research organization specializing in ceramic components and advanced material systems for medical and industrial applications.
Hirszfeld Institute of Immunology and Experimental Therapy
A Polish research center focused on immunology, experimental therapy, and the study of bacteriophages.
University of Latvia
A public research university in Riga contributing multidisciplinary academic expertise to the project.
NanoCarbonTech
A firm specializing in nanomaterial development and carbon-based research applications.
The details
The project uses electrospinning, a method for creating thin fabric membranes by drawing fibers from a polymer solution in a high-voltage electric field. These fibers are engineered to contain bacteriophages, which are recovered from hospital wastewater or lab cultures, to provide antimicrobial functions. By adding MXenes—a class of two-dimensional inorganic compounds—and proteins to the fiber matrix, researchers aim to promote skin cell regeneration while inhibiting bacterial growth.
Timeline
June 2024: The AntiMicroMXen project commenced.
May 2027: Development and integration of active ingredients is expected to be completed.
The Tech Race
This effort aligns with a broader push to modernize wound care through the M-ERA.NET research funding framework. It represents an attempt to move beyond conventional bandages by utilizing electrospinning technology, which has evolved for over 100 years.
This development is currently in the research phase and will not be available for clinical use or consumer purchase until the project concludes. Once completed, it could fundamentally change the workflow for treating chronic wounds in patients suffering from diabetes.
The takeaway
The AntiMicroMXen project highlights a move toward incorporating biological agents into synthetic medical textiles to fight antibiotic resistance. Observers should track the project's progress toward the May 2027 completion date to see if these membranes successfully transition to clinical testing.
What happens next
The project is scheduled to reach its milestone for the development and integration of active ingredients in May 2027.
Further reading
Learn more about the latest innovations in Materials Science regarding advanced membranes and fiber development.
More information
View the Fraunhofer research project information for additional details on the study's scope.
Source note: This article includes information reported by Informationdienst Wissenschaft e.V. - idw.
Live Poll
Should medical researchers prioritize developing natural alternatives to treat infections over traditional antibiotic treatments?
